We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBT
4676
Permian Basin Royalty Trust
PBT
$1.52B
$880K ﹤0.01%
99,259
+46,906
+90% +$430K
PETS icon
4677
PUT
PetMed Express
PETS
$42.1M
$878K ﹤0.01%
19,300
+6,700
+53% +$264K
HOLX
4678
PUT
DELISTED
Hologic
HOLX
$876K ﹤0.01%
20,500
+2,600
+15% +$104K
PLNT icon
4679
CALL
Planet Fitness
PLNT
$3.7B
$876K ﹤0.01%
25,300
-1,200
-5% -$35.5K
MATV icon
4680
Mativ Holdings
MATV
$706M
$875K ﹤0.01%
19,301
-6,840
-26% -$297K
VIVO
4681
DELISTED
Meridian Bioscience Inc
VIVO
$875K ﹤0.01%
62,515
-66,364
-51% -$971K
AIMT
4682
DELISTED
Aimmune Therapeutics
AIMT
$875K ﹤0.01%
23,133
-536,508
-96% -$17.3M
LM
4683
PUT
DELISTED
Legg Mason, Inc.
LM
$873K ﹤0.01%
20,800
-10,600
-34% -$416K
TECD
4684
CALL
DELISTED
Tech Data Corp
TECD
$872K ﹤0.01%
8,900
-15,700
-64% -$1.47M
HLX icon
4685
Helix Energy Solutions
HLX
$1.47B
$871K ﹤0.01%
115,550
-620,404
-84% -$4.39M
SGG
4686
CALL
DELISTED
iPath Bloomberg Sugar Subindex Total Return ETN due June 24, 2038
SGG
$871K ﹤0.01%
28,200
+7,400
+36% +$219K
ALKS icon
4687
CALL
Alkermes
ALKS
$8.29B
$870K ﹤0.01%
15,900
+11,500
+261% +$587K
AOS icon
4688
CALL
A.O. Smith
AOS
$8.48B
$870K ﹤0.01%
14,200
-4,200
-23% -$255K
BOIL icon
4689
CALL
ProShares Ultra Bloomberg Natural Gas
BOIL
$425M
$870K ﹤0.01%
13
+7
+117% +$513K
DELL icon
4690
CALL
Dell
DELL
$296B
$870K ﹤0.01%
38,127
-111,529
-75% -$2.53M
USD icon
4691
CALL
ProShares Ultra Semiconductors
USD
$2.8B
$870K ﹤0.01%
340,800
+100,800
+42% +$254K
AGIO icon
4692
PUT
Agios Pharmaceuticals
AGIO
$1.95B
$869K ﹤0.01%
15,200
+5,600
+58% +$352K
BANC icon
4693
PUT
Banc of California
BANC
$3B
$869K ﹤0.01%
42,100
+2,100
+5% +$43.9K
VOE icon
4694
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.2B
$869K ﹤0.01%
+7,786
New +$843K
INTF icon
4695
iShares International Equity Factor ETF
INTF
$3.74B
$868K ﹤0.01%
30,093
-100,893
-77% -$2.87M
ATCO
4696
DELISTED
Atlas Corp.
ATCO
$868K ﹤0.01%
128,660
+104,791
+439% +$684K
AB icon
4697
CALL
AllianceBernstein
AB
$3.45B
$867K ﹤0.01%
34,600
+8,200
+31% +$207K
UFCS icon
4698
United Fire Group
UFCS
$1.37B
$867K ﹤0.01%
19,026
-1,692
-8% -$79.1K
GBDC icon
4699
Golub Capital BDC
GBDC
$3.41B
$866K ﹤0.01%
+48,579
New +$899K
PAG icon
4700
PUT
Penske Automotive Group
PAG
$14.2B
$866K ﹤0.01%
18,100
+9,200
+103% +$433K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.